These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 17544941

  • 1. Sailing the straits of approval: the nature of FDA approval and its implications for surgeons.
    Reiter D.
    Facial Plast Surg Clin North Am; 2007 May; 15(2):247-50, vii-viii. PubMed ID: 17544941
    [Abstract] [Full Text] [Related]

  • 2. Understanding physician responsibilities and limitations for drug and device off-label use.
    Sclafani AP.
    Facial Plast Surg Clin North Am; 2007 May; 15(2):251-4, viii. PubMed ID: 17544942
    [Abstract] [Full Text] [Related]

  • 3. The use of Food and Drug Administration--approved medications for unlabeled (off-label) uses. The legal and ethical implications.
    Torres A.
    Arch Dermatol; 1994 Jan; 130(1):32-6. PubMed ID: 8285737
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prescribing medications in pediatrics: concerns regarding FDA approval and pharmacokinetics.
    Novak E, Allen PJ.
    Pediatr Nurs; 2007 Jan; 33(1):64-70. PubMed ID: 17411005
    [Abstract] [Full Text] [Related]

  • 6. Ethics, legal issues, and consent for fillers.
    Reisman NR.
    Clin Plast Surg; 2006 Oct; 33(4):505-10. PubMed ID: 17085219
    [Abstract] [Full Text] [Related]

  • 7. Are "off-labels" legal?
    Price EC.
    Mich Health Hosp; 1998 Oct; 34(6):20-1. PubMed ID: 10187136
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Off-label prescribing. Legal implications.
    Henry V.
    J Leg Med; 1999 Sep; 20(3):365-83. PubMed ID: 10530051
    [No Abstract] [Full Text] [Related]

  • 11. FDA reform signed into law. Food and Drug Administration.
    James JS.
    AIDS Treat News; 1997 Dec 05; (No 284):6-7. PubMed ID: 11364915
    [Abstract] [Full Text] [Related]

  • 12. Unapproved uses of approved drugs: the physician, the package insert, and the Food and Drug Administration: subject review. American Academy of Pediatrics Committee on Drugs.
    Pediatrics; 1996 Jul 05; 98(1):143-5. PubMed ID: 8668390
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic monoclonal antibodies: trends in development and approval in the US.
    Reichert JM.
    Curr Opin Mol Ther; 2002 Apr 05; 4(2):110-8. PubMed ID: 12044031
    [Abstract] [Full Text] [Related]

  • 14. Lost in translation: differences in antimicrobial indication approval policies between the United States and Europe.
    Pappas G, Ierodiakonou V, Falagas ME.
    Clin Ther; 2009 Jul 05; 31(7):1595-603. PubMed ID: 19695409
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Off-label use of prescription medication: nursing implications.
    Keltz JM.
    Nephrol Nurs J; 2003 Feb 05; 30(1):99-100. PubMed ID: 12674960
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.